← Back to Search

PulsePoint App for Cardiac Arrest

N/A

Recruiting

Led By John M Tallon, MD MSc

Research Sponsored by Dr. Steven Brooks

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with 911 calls assigned as "suspected" or "confirmed" cardiac arrest and, Are confirmed to be EMS-treated, public location out-of-hospital cardiac arrest.

Must not have

Traumatic cardiac arrest, or Cardiac arrests occurring in the context of a dangerous scene as determined by the 9-1-1 call-taker, or EMS-witnessed cardiac arrest, or Cardiac arrests not treated by EMS ("Do Not Resuscitate", signs of obvious death), or Cardiac arrests occurring in nursing homes and health care facilities.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this will be tracked for each notification event that occurs during the anticipated 2 year accrual time frame.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether an app that alerts bystanders of a nearby cardiac arrest can increase the rate of CPR or defibrillator use.

Who is the study for?

The PulsePoint Study is for patients who experience a non-traumatic, out-of-hospital cardiac arrest in public. They must be treated by EMS and have their condition confirmed as 'suspected' or 'confirmed' cardiac arrest. It excludes those with traumatic arrests, arrests at dangerous scenes, EMS-witnessed events, cases not treated by EMS (like DNRs), or incidents in nursing homes/healthcare facilities.

What is being tested?

This study tests if the PulsePoint system can increase bystander CPR or defibrillator use when someone has a cardiac arrest in public. Participants are randomly divided into two groups: one receives PulsePoint alerts plus standard dispatch; the other gets only standard dispatch.

What are the potential side effects?

Since this trial involves an alert system rather than a medical intervention, there are no direct side effects from drugs or treatments to list.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had a cardiac arrest in a public place and was treated by EMS.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My cardiac arrest was traumatic, in a dangerous place, witnessed by EMS, or I wasn't treated due to a DNR.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this will be tracked for each notification event that occurs during the anticipated 2 year accrual time frame.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this will be tracked for each notification event that occurs during the anticipated 2 year accrual time frame.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this will be tracked for each notification event that occurs during the anticipated 2 year accrual time frame. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of patients receiving bystander resuscitation

Secondary study objectives

EMS on scene time interval (secondary safety outcome)

EMS response time interval (secondary safety outcome)

False positive rate for PulsePoint activation (secondary system performance outcome)

+10 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Conventional Emergency Dispatch PLUS PulsePoint notificationExperimental Treatment1 Intervention

Eligible 911 calls randomized to the experimental arm of the study will undergo usual dispatch of emergency services personnel as per pre-existing local protocols and activation of the PulsePoint system. When triggered, the system will push location data to all PulsePoint mobile application users within 400 meters of the emergency. Devices receiving the alerts from the PulsePoint system will alarm with auditory, tactile and visual stimuli. The application will present a map showing the exact location of the emergency and the closest public access defibrillator.

Group II: Conventional Emergency DispatchActive Control1 Intervention

Patients randomized to the control arm will receive conventional emergency medical dispatching procedures as per pre-existing local protocols (e.g. dispatch of emergency vehicles, attempted dispatch-assisted CPR) without activation of the PulsePoint system. 911 calls randomized to the control arm will not be associated with any PulsePoint alerts.

0 / 2Eligibility criteria met